Detalles de la búsqueda
1.
Cognitive Effects of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease with GBA1 Pathogenic Variants.
Mov Disord
; 38(12): 2155-2162, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37916476
2.
Increased Subthalamic Nucleus Deep Brain Stimulation Amplitude Impairs Inhibitory Control of Eye Movements in Parkinson's Disease.
Neuromodulation
; 25(6): 866-876, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34139037
3.
Subthalamic Physiology in Genetic Subtypes of Parkinson's Disease.
Mov Disord
; 38(6): 1113-1114, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37475610
4.
Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation.
Mov Disord
; 32(2): 274-277, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27911008
5.
Benefits of subthalamic nucleus deep brain stimulation on visually-guided saccades depend on stimulation side and classic paradigm in Parkinson's disease.
Clin Neurophysiol
; 162: 41-52, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38555666
6.
The Effects of Subthalamic Nucleus Deep Brain Stimulation and Retention Delay on Memory-Guided Reaching Performance in People with Parkinson's Disease.
J Parkinsons Dis
; 13(6): 917-935, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37522216
7.
Medication only improves limb movements while deep brain stimulation improves eye and limb movements during visually-guided reaching in Parkinson's disease.
Front Hum Neurosci
; 17: 1224611, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37850040
8.
Encoding type, medication, and deep brain stimulation differentially affect memory-guided sequential reaching movements in Parkinson's disease.
Front Neurol
; 13: 980935, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36324383
9.
Medication adversely impacts visually-guided eye movements in Parkinson's disease.
Clin Neurophysiol
; 143: 145-153, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35995722
10.
Motor Evoked Potential Recordings During Segmented Deep Brain Stimulation-A Feasibility Study.
Oper Neurosurg (Hagerstown)
; 20(4): 419-425, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33428767
11.
Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot Study.
Front Neurol
; 12: 723476, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34659089
12.
Genetic and Clinical Predictors of Deep Brain Stimulation in Young-Onset Parkinson's Disease.
Mov Disord Clin Pract
; 3(5): 465-471, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27709117
13.
The Core Assessment Program for Surgical Interventional Therapies in Parkinson's Disease (CAPSIT-PD): Tolerability of Preoperative Neuropsychological Testing for Deep Brain Stimulation in Parkinson's Disease.
Mov Disord Clin Pract
; 2(4): 379-383, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30363547
14.
Abnormal lipopolysaccharide binding protein as marker of gastrointestinal inflammation in Parkinson disease.
Front Neurosci
; 9: 306, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26388718
15.
Validating the targets for neurostimulation in essential tremor.
Neurology
; 91(6): 247-248, 2018 08 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29970402
16.
Muscle Contraction as a False Localizing Sign During Intraoperative Macrostimulation of Subthalamic Nucleus.
Mov Disord Clin Pract
; 2(1): 64-65, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30363753
Resultados
1 -
16
de 16
1
Próxima >
>>